![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 23
Zeitschriftenartikel
Reichenbach, Juliane; Fraungruber, Patricia; Mayr, Doris; Buschmann, Christina; Kraus, Fabian B. T.; Topalov, Nicole Elisabeth; Chelariu-Raicu, Anca; Kolben, Thomas; Burges, Alexander; Mahner, Sven 
ORCID: https://orcid.org/0000-0002-2224-5709; Kessler, Mirjana; Jeschke, Udo; Czogalla, Bastian und Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350
(2023):
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 11: S. 8719-8728
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-2224-5709; Kessler, Mirjana; Jeschke, Udo; Czogalla, Bastian und Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350
(2023):
Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 11: S. 8719-8728
[PDF, 2MB]
Badmann, Susann; Mayr, Doris; Schmoeckel, Elisa; Hester, Anna; Buschmann, Christina; Beyer, Susanne; Kolben, Thomas; Kraus, Fabian; Chelariu-Raicu, Anca; Burges, Alexander; Mahner, Sven; Jeschke, Udo; Trillsch, Fabian und Czogalla, Bastian
(3. Februar 2022):
AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.
In: Scientific Reports, Bd. 12
[PDF, 3MB]
Chelariu-Raicu, Anca ORCID: https://orcid.org/0000-0003-2944-9488; Holley, Eva; Mayr, Doris; Klauschen, Frederick; Wehweck, Fabienne; Rottmann, Miriam; Kessler, Mirjana; Kaltofen, Till; Czogalla, Bastian; Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709 und Schmoeckel, Elisa ORCID: https://orcid.org/0000-0001-7199-3837
(2022):
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
In: International Journal of Gynecologic Cancer, Bd. 32, Nr. 5: S. 662-668
ORCID: https://orcid.org/0000-0003-2944-9488; Holley, Eva; Mayr, Doris; Klauschen, Frederick; Wehweck, Fabienne; Rottmann, Miriam; Kessler, Mirjana; Kaltofen, Till; Czogalla, Bastian; Trillsch, Fabian ORCID: https://orcid.org/0000-0002-1860-4350; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709 und Schmoeckel, Elisa ORCID: https://orcid.org/0000-0001-7199-3837
(2022):
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
In: International Journal of Gynecologic Cancer, Bd. 32, Nr. 5: S. 662-668
Batz, Falk; Lermer, Eva; Hatzler, Laura; Vilsmaier, Theresa; Schroeder, Lennard; Chelariu-Raicu, Anca; Behr, Joachim; Mahner, Sven; Buspavanich, Pichit und Thaler, Christian J.
(2022):
The Impact of the COVID-19 Pandemic on Sexual Health in Cis Women Living in Germany.
In: Journal of Sexual Medicine, Bd. 19, Nr. 6: S. 907-922
Hillemeyer, Lara; Espinoza-Sanchez, Nancy Adriana; Greve, Burkhard; Hassan, Nourhan; Chelariu-Raicu, Anca; Kiesel, Ludwig und Goette, Martin
(2022):
The Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 Promotes Ovarian Cancer Pathogenesis.
In: International Journal of Molecular Sciences, Bd. 23, Nr. 10, 5793
Nikolova, Tanja; Bossart, Michaela; Kacperczyk-Bartnik, Joanna; Razumova, Zoia; Strojna, Alexandra; Bizzarri, Nicolo; Pletnev, Andrei; Gomez-Hidalgo, Natalia R.; Theofanakis, Charalampos; Lanner, Maximilian; Selcuk, Ilker; Shushkevich, Alexander; Chelariu-Raicu, Anca; Nikolova, Natasha; Concin, Nicole und Zalewski, Kamil
(2022):
Gender-related differences in career development among gynecologic oncology surgeons in Europe. European Network of Young Gynecologic Oncologists' Survey based data.
In: Frontiers in Oncology, Bd. 12, 1005130
Chelariu-Raicu, Anca; Mahdi, Haider und Slomovitz, Brian M.
(2022):
Changing treatments paradigms and role of immunotherapy in recurrent endometrial cancer.
In: Current Opinion in Obstetrics & Gynecology, Bd. 34, Nr. 1: S. 28-35
Ye, Yao; Peng, Lin; Chelariu-Raicu, Anca; Kuhn, Christina; Dong, Xi; Jeschke, Udo und Schoenfeldt, Viktoria von
(2022):
Prostaglandin E2 receptor 3 promotes M1 macrophages polarization in unexplained recurrent pregnancy loss.
In: Biology of Reproduction, Bd. 106, Nr. 5, ioac030: S. 910-918
Topalov, Nicole Elisabeth; Mayr, Doris; Scherer, Clemens; Chelariu-Raicu, Anca; Beyer, Susanne; Hester, Anna; Kraus, Fabian; Zheng, Mingjun; Kaltofen, Till; Kolben, Thomas; Burges, Alexander; Mahner, Sven; Trillsch, Fabian; Jeschke, Udo und Czogalla, Bastian
(23. September 2021):
Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer.
In: Frontiers in Oncology, Bd. 11, 713026
[PDF, 2MB]
Ma, Zhi; Yang, Huixia; Peng, Lin; Kuhn, Christina; Chelariu-Raicu, Anca; Mahner, Sven; Jeschke, Udo und Schönfeldt, Viktoria von
(31. Mai 2021):
Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages.
In: Frontiers in Immunology, Bd. 12, 679424
[PDF, 11MB]
Peng, Lin; Chelariu-Raicu, Anca; Ye, Yao; Ma, Zhi; Yang, Huixia; Ishikawa-Ankerhold, Hellen; Rahmeh, Martina; Mahner, Sven; Jeschke, Udo und Schönfeldt, Viktoria von
(2021):
Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage.
In: International Journal of Molecular Sciences, Bd. 22, Nr. 17, 9134
Zheng, Mingjun; Long, Junyu; Chelariu-Raicu, Anca; Mullikin, Heather; Vilsmaier, Theresa; Vattai, Aurelia; Heidegger, Helene Hildegard; Batz, Falk; Keckstein, Simon; Jeschke, Udo; Trillsch, Fabian; Mahner, Sven und Kaltofen, Till
(2021):
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.
In: Cancers, Bd. 13, Nr. 13, 3343
Westin, Shannon N.; Labrie, Marilyne; Litton, Jennifer K.; Blucher, Aurora; Fang, Yong; Vellano, Christopher P.; Marszalek, Joseph R.; Feng, Ningping; Ma, XiaoYan; Creason, Allison; Fellman, Bryan; Yuan, Ying; Lee, Sanghoon; Kim, Tae-Beom; Liu, Jinsong; Chelariu-Raicu, Anca; Chen, Tsun Hsuan; Kabil, Nashwa; Soliman, Pamela T.; Frumovitz, Michael; Schmeler, Katheleen M.; Jazaeri, Amir; Lu, Karen H.; Murthy, Rashmi; Meyer, Larissa A.; Sun, Charlotte C.; Sood, Anil K.; Coleman, Robert L. und Mills, Gordon B.
(2021):
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
In: Clinical Cancer Research, Bd. 27, Nr. 23: S. 6354-6365
Vogelsang, Tilman L. R.; Vattai, Aurelia; Schmoeckel, Elisa; Kaltofen, Till; Chelariu-Raicu, Anca; Zheng, Mingjun; Mahner, Sven; Mayr, Doris; Jeschke, Udo und Trillsch, Fabian
(2021):
Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.
In: International Journal of Molecular Sciences, Bd. 22, Nr. 16, 8479
Mustachio, Lisa Maria; Chelariu-Raicu, Anca; Szekvolgyi, Lorant und Roszik, Jason
(2021):
Targeting KRAS in Cancer: Promising Therapeutic Strategies.
In: Cancers, Bd. 13, Nr. 6, 1204
Hinchcliff, Emily; Chelariu-Raicu, Anca und Westin, Shannon N.
(2021):
Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance.
In: Current Opinion in Obstetrics & Gynecology, Bd. 33, Nr. 1: S. 19-25
Forster, Marie; Würstlein, Rachel; Koenig, Alexander; Amann, Niklas; Beyer, Susanne; Kaltofen, Till; Degenhardt, Tom; Burges, Alexander; Trillsch, Fabian; Mahner, Sven; Harbeck, Nadia und Chelariu-Raicu, Anca
(2021):
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective.
In: Breast, Bd. 60: S. 214-222
Deuster, Eileen; Hysenaj, Ivi; Kahaly, Maja; Schmoeckel, Elisa; Mayr, Doris; Beyer, Susanne; Kolben, Thomas; Hester, Anna; Kraus, Fabian; Chelariu-Raicu, Anca; Burges, Alexander; Mahner, Sven; Jeschke, Udo; Trillsch, Fabian und Czogalla, Bastian
(2021):
The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
In: Cells, Bd. 10, Nr. 9, 2337
Chelariu-Raicu, Anca; Nick, Alpa; Urban, Renata; Gordinier, Mary; Leuschner, Carola; Bavisotto, Linda; Dal Molin, Graziela Zibetti; Whisnant, John K. und Coleman, Robert L.
(2021):
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer.
In: Gynecologic Oncology, Bd. 160, Nr. 2: S. 418-426
Chelariu-Raicu, Anca und Harbeck, Nadia
(2021):
Treatment Landscape of Ductal Carcinoma In Situ.
In: Chirurgia, Bd. 116, Nr. 5:
S76-S82
Chelariu-Raicu, Anca; Cobb, Lauren P. und Gershenson, David M.
(2021):
Fertility preservation in rare ovarian tumors.
In: International Journal of Gynecological Cancer, Bd. 31, Nr. 3: S. 432-441
Kim, Mark Seungwook; Ma, Shaolin; Chelariu-Raicu, Anca; Leuschner, Carola; Alila, Hector W.; Lee, Sanghoon; Coleman, Robert L. und Sood, Anil K.
(2020):
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer.
In: Molecular Cancer Therapeutics, Bd. 19, Nr. 11: S. 2396-2406
Zheng, Mingjun; Mullikin, Heather; Hester, Anna; Czogalla, Bastian; Heidegger, Helene; Vilsmaier, Theresa; Vattai, Aurelia; Chelariu-Raicu, Anca; Jeschke, Udo; Trillsch, Fabian; Mahner, Sven und Kaltofen, Till
(2020):
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.
In: International Journal of Molecular Sciences, Bd. 21, Nr. 23, 9169